Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ETX-19477 by 858 Therapeutics for Solid Tumor: Likelihood of Approval
ETX-19477 is under clinical development by 858 Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...